About Aalto Bio Reagents
Aalto Bio Reagents is a company based in Dublin (Ireland) founded in 1978 was acquired by Biosynth Carbosynth in May 2022. Aalto Bio Reagents offers products and services including Recombinant Antigens, Monoclonal Antibodies, Bulk Antigens, and Disease State Plasma. Aalto Bio Reagents operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aalto Bio Reagents Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aalto Bio Reagents
Aalto Bio Reagents offers a comprehensive portfolio of products and services, including Recombinant Antigens, Monoclonal Antibodies, Bulk Antigens, and Disease State Plasma.
Custom manufactured antigens for disease testing and research
Antibodies used in diagnostics for human and veterinary diseases
Routine antigens for chemiluminescence platforms and controls
Plasma for diagnostic controls and testing purposes
Funding Insights of Aalto Bio Reagents
Detailed funding history for Aalto Bio Reagents
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Aalto Bio Reagents
Aalto Bio Reagents has secured backing from 1 investor. Prominent investors backing the company include Biosynth Carbosynth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of drug discovery, manufacturing, supply chain, regulatory support, and other services
|
Locked | Locked | Locked |
Investor details for Aalto Bio Reagents
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aalto Bio Reagents
Investment portfolio details for Aalto Bio Reagents
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aalto Bio Reagents
Detailed financials for Aalto Bio Reagents
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aalto Bio Reagents Comparisons
Peer comparison for Aalto Bio Reagents
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aalto Bio Reagents
Aalto Bio Reagents operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Antibody and vaccine culture media products are developed.
|
Detailed competitors of Aalto Bio Reagents
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aalto Bio Reagents
Complete news archive for Aalto Bio Reagents
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aalto Bio Reagents
Aalto Bio Reagents was founded in 1978.
Aalto Bio Reagents is headquartered in Dublin, Ireland.
Founded in 1978 in Dublin, Ireland, Aalto Bio Reagents operates in the in-vitro diagnostics sector. Raw materials such as purified human proteins, monoclonal and polyclonal antibodies, fungal, parasitic, bacterial, and viral antigens, and disease state plasma are developed, manufactured, and marketed for diagnostic applications and research. DIY assay protocols for HIV-1-p24gag and HIV-1 gp120 env are offered to AIDS research labs. Molecular controls for the IVD industry are under development.
Aalto Bio Reagents's top competitors include Sino Biological, GenScript and Y-Biologics.
Aalto Bio Reagents offers Recombinant Antigens, Monoclonal Antibodies, Bulk Antigens, and Disease State Plasma.
Aalto Bio Reagents has 1 investor. Key investors include Biosynth Carbosynth.